Karyopharm Therapeutics (KPTI)
(Delayed Data from NSDQ)
$0.96 USD
-0.06 (-6.23%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $0.95 -0.01 (-0.68%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Brokerage Reports
Karyopharm Therapeutics Inc. [KPTI]
Reports for Purchase
Showing records 361 - 380 ( 387 total )
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
Week Ahead in Life Sciences - Upcoming Events for the Week of Dec. 7th
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of Dec. 7th
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of Nov. 23
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
3Q EPS; Comprehensive Clinical Program Set Up for Busy 2016; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
Selinexor Sepsis Concerns Overdone, Risk/Reward Attractive, Reiterate OP and Reducing PT to $39 on Timing
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
HEALTHCARE: 2015 Wedbush PacGrow Healthcare Conference Day 2
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of June 22
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
EHA Congress Presentations: Selinexor Demonstrating Durable Responses in Heavily Pre-treated DLBCL Patients; Activity in AML
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
At ASCO, Selinexor Shows Single-Agent Activity in Range of Solid Tumors, Reiterate OUTPERFORM rating
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
ASCO, Selinexor Shows Single- Agent Activity in Range of Solid Tumors, Reiterate OUTPERFORM rating
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of May 25th
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
Selinexor Shows Synergy with Chemo in Difficult to Treat AML Setting, Further Updates in AML and DLBCL Expected at EHA, Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of May 25th
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
Week Ahead in Life Sciences - Upcoming Events for the Week of May 18th
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
1Q15 Earnings, ASCO Abstracts Will Shed Light on Selinexor Potential in Solid Tumors, Maintain Outperform
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of May 11th
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
4Q14 Earnings, Aggressive Clinical Development Plan on Track, Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of March 16th
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
Selinexor Update in NHL and MM Shows High Response Rates Maintained, Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D